This Week In Weed – 14 October 2018

GW raises $345m on US stock exchange UK biopharmaceutical company GW Pharmaceuticals, a global developer of medical cannabis products, has released 2.1 million shares on the US stock exchange, raising US$345m. The move comes four months after CBD medicine Epidiolex, manufactured by GW Pharmaceuticals’ subsidiary Greenwich Biosciences, became the first cannabis-derived medicine approved for use […]

Continue Reading